BBB Foods Heads Into First Print with Analysts Chasing the Stock Higher
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
TBBB reports its first earnings as a listed company today with analyst price targets still trailing the share price, short sellers retreating, and the CEO holding a Schedule 13D activist stake, an unusual combination for a food retailer heading into an inaugural print.
The most newsworthy fact in the ownership register is that Chairman and CEO Kamal Anthony Hatoum filed a Schedule 13D on 17 June 2026, disclosing a 17.6% stake. A 13D signals active rather than passive intent. Hatoum is the company's largest declared holder, and his filing predates a strong run in the stock. As required by SEC rules, stakes here are "as last disclosed" around the 5% threshold, and holders dropping below that level may exit without a further filing.
Short positioning tells a calm story heading into the release. Short interest has fallen nearly 10% over the past week to just under 5% of the free float, roughly 3 million shares, with borrowing costs at a negligible 0.50% and borrow availability at more than 2,200% of outstanding short interest. That means lenders have more than twenty-two times as many shares on offer as are currently borrowed. There is no meaningful squeeze pressure in the lending market.
Options markets reinforce the relaxed tone. The put/call ratio is running at 0.27, below its 20-day average of 0.30 and far short of the 52-week high of 0.61. Call-side demand has dominated into the print, with no sign of the defensive hedging that often appears ahead of uncertain reports. The ORTEX short score has also drifted lower over the past two weeks, from 47 in mid-October to 41 today, consistent with a gradual unwind of short-side conviction.
Analysts are broadly bullish but have been chasing the stock rather than leading it. UBS raised its target to $69 on 21 October, two weeks ago, from $58, maintaining a Buy. JP Morgan holds an Overweight with a $67 target set in September. The stock closed at $56.97 on 2 November, up roughly 8% over the past month, so the targets now sit above the current price but not by a wide margin. What the Street is debating is whether a Mexican value-grocery operator can sustain the unit economics that justified the multiple expansion since listing. The trailing PE is highly elevated and the EV/EBITDA of 22.6x has compressed about 1.4 turns over the past thirty days, a modest derating that has not deterred bullish target upgrades. The stock has a perfect 100th-percentile ranking on EPS surprise, meaning it has consistently beaten estimates, though the forward EPS momentum scores near the bottom of the market with ranks of 1 and 2 on 30- and 90-day readings, reflecting slowing upgrade momentum after an aggressive upcycle.
Capital Research and Management Company added nearly 2.9 million shares in the most recent reported period, bringing its stake to 11.7% of shares, while Capital International Investors built to 11.3% after filing an amendment disclosing an increase from 8.7%. Those are sizeable institutional commitments. On the other side, Quilvest Capital Partners has cut sharply from 15.6% to 3.5% as last disclosed, and several other holders have trimmed. The prior two earnings-adjacent prints saw the stock jump 13% and 19% on the day respectively, though the composition of those moves and what drove them is unclear from available data.
The print will test whether TBBB's unit volumes and margin trajectory in Mexico can justify a valuation that the analyst community has been revising upward at every step, even as the stock has already outrun several of those targets.
Stocks in this article
See the live data behind this article on ORTEX.
Open TBBB on ORTEX →How this article was generated
- Generated
- 3 Nov 2026, 05:58
- Data as of
- 3 Nov 2026, 05:04
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.